Multiple Myeloma News and Research

Latest Multiple Myeloma News and Research

Daisy compound used to attack cancer stem cells

Daisy compound used to attack cancer stem cells

Gene profiling can single out the worst cases of multiple myeloma and guide therapy

Gene profiling can single out the worst cases of multiple myeloma and guide therapy

C-reactive protein shown to be a potential target for cancer treatment

C-reactive protein shown to be a potential target for cancer treatment

Mechanism identified that plays a critical role in multiple myeloma cell cycle and survival

Mechanism identified that plays a critical role in multiple myeloma cell cycle and survival

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Revlimid receives approval in Switzerland for treatment of multiple myeloma

New anti-cancer drug made from corn lillies kills brain tumor stem cells

New anti-cancer drug made from corn lillies kills brain tumor stem cells

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

New drug targets for multiple myeloma

New drug targets for multiple myeloma

Mortality rates from pulmonary fibrosis will continue to rise

Mortality rates from pulmonary fibrosis will continue to rise

Obesity a risk factor for multiple myeloma

Obesity a risk factor for multiple myeloma

Obesity a risk factor for multiple myeloma

Obesity a risk factor for multiple myeloma

Myeloma cancer drug gets the green light from the EU

Myeloma cancer drug gets the green light from the EU

Foie gras can speed amyloid development

Foie gras can speed amyloid development

Transplantation does not benefit patients with refractory myeloma

Transplantation does not benefit patients with refractory myeloma

Revlimid may change the way physicians treat multiple myeloma

Revlimid may change the way physicians treat multiple myeloma

Scientists develop a more human-like mouse model of cancer

Scientists develop a more human-like mouse model of cancer

FDA approves VELCADE plus DOXIL combination for multiple myeloma

FDA approves VELCADE plus DOXIL combination for multiple myeloma

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Patients with myelodysplastic syndromes treated with Revlimid are living longer and remaining transfusion independent

Multiple myeloma dexamethasone / lenalidomide trial closes

Multiple myeloma dexamethasone / lenalidomide trial closes

Novel targeted therapy effectively treats acute leukemia

Novel targeted therapy effectively treats acute leukemia